Please login to the form below

Not currently logged in
Email:
Password:

INC Research appoints Robert Ryan

Joins CRO's new Strategic Advisory Services unit

INC Research Robert RyanINC Research has appointed Robert Ryan as vice president of regulatory strategy, consulting and submissions within its new Strategic Advisory Services unit.

He joins the contract research organisation (CRO) from CNS and pain-focused pharmaceutical development company Levare, where he was chairman of the board.

Prior to this Ryan spent time with other CROs and biopharmaceutical companies, including Quintiles, PPD, Celtic Therapeutics and Schwarz Pharma.

In his new role at INC Ryan will be tasked with positioning INC's new Strategic Advisory Services as a market leader in regulatory consulting and submissions offerings.

Tim Dietlin, senior vice president of global consulting and strategic alliances, said: "Robert brings a unique blend of strategic leadership skills and international regulatory expertise that speaks to biopharmaceutical companies looking for guidance along the entire continuum of the drug development life cycle.

"Our Regulatory Consulting and Submissions team has a long history of exceptional work, and we look forward to continuing this track record under Robert's leadership."

10th December 2012

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics